Genetic variants screening for solid tumors
SOLIDaccuTest™ is an excellent tool to explorer variants associated with solid tumors using a comprehensive method of next-generation sequencing (NGS). It reflects the latest research trends and is optimized for the medical purpose by selecting essential genes of solid tumors including lung, colon, breast, skin brain, gastric, ovarian cancers, etc.
Working Process
Specification
| SOLIDaccuTest™ | ||
|---|---|---|
| DNA | RNA | |
| Certification | CE-IVD | RUO |
| Target disease | Lung, gastric, colon, breast/ovarian cancer and melanoma, etc. | |
| Target Enrichment method | Hybridization & capture method | |
| Quantity | 96 tests/kit (8 runs per kit, up to 12 samples per run) | |
| Specimen | FFPE tissue, biopsyTumor %: >20% | |
| Target gene | 84 genes | 29 genes |
| Target size | 270 kb | 80 kb |
| Turn around time | 3 days | 3.5 days |
| Variants type | SNV, INDEL, CNV* | Fusion |
| NGS platform | illumina MiSeq, MiSeq Dx / MiSeq Reagent kit, v3, 300cycles | |
| Analysis solution | NGeneAnalySys™ (CE) | |
Ordering information
| Products | Cat.no | Quantity | |
|---|---|---|---|
| RUO | CE-IVD | ||
| SOLIDaccuTest™ DNA & NGeneAnalySys™ | NGB131R-096 |
NGB131V-096 |
96 tests |
NGB131R-048 |
NGB131V-048 |
48 tests |
|
| SOLIDaccuTest™ RNA & NGeneAnalySys™ | NGB132R-096 |
On the Process |
96 tests |
NGB132R-048 |
48 tests |
||